Smart-Money SignalDistribution · 42/100— Insiders are net sellers over 90 days (-$168K, 14 sales vs 10 buys)
Revenue$71.4M
Net Income-$79.0M
EPS$-0.19
Market Cap$1.9B
Price Performance
Historical data including institutional events
Company Profile
F
Frederick Vogt
CEO & Executive Director
Iovance Biotherapeutics, Inc. is a biopharmaceutical startup based in San Carlos, California. The company works to develop tumor-infiltrating lymphocyte (TIL) therapies against cancer.
